CIK 0001662579
- Non-accelerated filer
- Smaller reporting company
C4 Therapeutics, Inc.
Sign in to watch- Ticker
- CCCC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 475617627
- Phone
- +1 617-231-0700
- Business address
- 490 ARSENAL WAY, SUITE 120, WATERTOWN, MA, 02472
- 4 Shares withheld for taxes Chief Legal Officer gave up 1,735 shares (to pay taxes)
- 4 Shares withheld for taxes Chief People Officer gave up 1,735 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 2,255 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Business Officer gave up 1,735 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 1,301 shares (to pay taxes)
- 4 Grant or award Director acquired 1,687 shares (grant or award)
- 4 Grant or award Director acquired 1,725 shares (grant or award)
- 4 Grant or award Director acquired 2,108 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 6,617 shares (grant or award)
- 4 Grant or award Director acquired 6,470 shares (grant or award)
- 4 Grant or award Director acquired 8,089 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Financial Officer acquired 25,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
Page 6 of 15 · 296 filings